A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media (Q70382882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

A randomized controlled trial of cefaclor compared with trimethoprim-sulfamethoxazole for treatment of acute otitis media (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

randomized controlled trial

10 October 2019

main subject

1 reference

1 reference

1 reference

C D Marchant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

P A Shurin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

V A Turcyzk

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

J C Feinstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

C E Johnson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

D E Wasikowski

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

L J Knapp

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

M A Tutihasi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 October 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

10 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

633-638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

Otitis media caused by non-typable, ampicillin-resistant strains of Haemophilus influenzae

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Increasing incidence of ampicillin resistance in Hemophilus influenzae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Clinical biostatistics. LIV. The biostatistics of concordance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Stability and Blood Level Determinations of Cefaclor, a New Oral Cephalosporin Antibiotic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Absorption and Urinary Execretion of Trimethoprim, Sulfamethoxazole, and Trimethoprim-Sulfamethoxazole: Results with Single Doses in Normal Young Adults and Preliminary Observations during Therapy with Trimethoprim-Sulfamethoxazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Cefaclor therapy twice daily for acute otitis media. Controlled comparative study of twice-daily vs thrice-daily dose schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Pharmacokinetics of cefaclor in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Cefaclor: in vitro spectrum of activity and beta-lactamase stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Growth Curves, Microscopic Morphology, and Subcultures of Beta-Lactamase-Positive and -Negative Haemophilus influenzae Under the Influence of Ampicillin and Cefamandole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Quantitative cultures of middle-ear fluid in acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

7 January 2021

Therapy of Otitis Media

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

A trial comparing cefaclor with co-trimoxazole in the treatment of acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identification of otitis media with effusion in children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2884%2980438-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(84)80438-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384453%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference